This podcast discusses the Centers for Medicare & Medicaid Services (CMS) Outpatient Prospective Payment System (OPPS) proposed rule, with a focus on its cuts to the 340B Drug Pricing Program. We discuss CMS’s proposed cuts to 340B reimbursement and proposed changes to recoupment of 340B overpayments from 2018 – 2022, as well as how these changes interact with other challenges to the 340B program.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.